Cephalon sues Sandoz over Fentora cancer drug

Sept 16 (Reuters) - Cephalon Inc on Friday sued Novartis AG's Sandoz drug unit, accusing it of trying to infringe two patents related to its Fentora drug that treats pain in adults who have cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.